Dalata Hotel Group PLC / IE00BJMZDW83
07.10.2025 - 08:00:05Announcement in relation to European Commission Clearance and Date of Court Hearing to sanction scheme
Dalata Hotel Group PLC (DAL,DHG) 07-Oct-2025 / 07:00 GMT/BST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION FOR IMMEDIATE RELEASE 7 October 2025 RECOMMENDED CASH OFFER FOR DALATA HOTEL GROUP PLC BY PANDOX IRELAND TUCK LIMITED A NEWLY-INCORPORATED COMPANY WHOLLY-OWNED BY PANDOX AB AND EIENDOMSSPAR AS TO BE IMPLEMENTED BY WAY OF A SCHEME OF ARRANGEMENT UNDER CHAPTER 1 OF PART 9 OF THE COMPANIES ACT 2014 RECEIPT OF EUROPEAN COMMISSION CLEARANCE AND ANNOUNCEMENT OF DATE OF COURT HEARING TO SANCTION SCHEME On 15 July 2025, Dalata Hotel Group plc (“Dalata”) and Pandox Ireland Tuck Limited (“Bidco”) announced a recommended cash offer for the entire issued and to be issued share capital of Dalata by Bidco (the “Acquisition”), to be implemented by way of a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014 (the “Scheme”), which is subject to the terms and conditions set out in the scheme document published by Dalata on 12 August 2025 (the "Scheme Document"). Dalata Shareholders voted in favour of the Acquisition at the Scheme Meetings and Extraordinary General Meeting held on 11 September 2025. Receipt of European Commission Clearance The Board of Dalata are pleased to announce that it has been notified that the EU Commission has made its determination in respect of the Acquisition and has concluded that it may be put into effect. Accordingly, Condition 3.2 of Part V of the Scheme Document has been satisfied. Announcement of Date of Court Hearing to Sanction the Scheme The Board of Dalata also announces that the Court Hearing, where sanction of the Scheme by the High Court of Ireland (the “Court”) will be sought, has been set for 11.00 am on Wednesday, 29 October 2025. Information on the Court Hearing (or, if relevant, a change in the date of the Court Hearing) will be advertised on the Company's website www.dalatahotelgroup.com. By Order of the Court, any interested party intending to appear at the hearing must give notice of their intention to do so to the Company’s solicitors, A&L Goodbody LLP, by no later than 6pm (GMT) on Thursday 23 October 2025. Any affidavit evidence that an interested party intends to rely on at the hearing shall be filed with the Central Office of the Court and served on the Company’s solicitors, A&L Goodbody LLP, by that time and date (i.e. 6pm (GMT) on Thursday 23 October 2025). A copy of the originating notice of motion and the supporting affidavit may be obtained from the Company’s solicitors A&L Goodbody LLP, upon request made by email addressed to dalatahotelgroup@algoodbody.com. Timetable Subject to satisfaction or waiver of the other Conditions set out in the Scheme Document, including the sanction by the Court of the Scheme at the Court Hearing, the Effective Date of the Scheme and closing of the transaction is expected to be early November 2025. Except as otherwise defined herein, capitalised terms used but not defined in this announcement have the same meanings as given to them in the Scheme Document. Enquiries
Disclosure requirements of the Takeover Rules Under Rule 8.3(b) of the Irish Takeover Rules, any person 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Dalata must disclose all 'dealings' in such 'relevant securities' during the 'offer period'. The disclosure of a 'dealing' in 'relevant securities' by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (Irish/UK time) on the business day following the date of the relevant transaction. This requirement will continue until the 'offer period' ends. If two or more persons cooperate on the basis of any agreement either express or tacit, either oral or written, to acquire an 'interest' in 'relevant securities' of the offeree company, they will be deemed to be a single person for the purpose of Rule 8.3 of the Irish Takeover Rules. A dealing disclosure must contain the details specified in Rule 8.6(b) of the Irish Takeover Rules, including details of the dealing concerned and of the person's interests and short positions in any 'relevant securities' of Dalata. All 'dealings' in 'relevant securities' of Dalata by a bidder, or by any party Acting in Concert with a bidder, must also be disclosed by no later than 12 noon (Irish/UK time) on the 'business' day following the date of the relevant transaction. If two or more persons co-operate on the basis of an agreement, either express or tacit, either oral or written, to acquire for one or more of them an interest in relevant securities, they will be deemed to be a single person for these purposes. Disclosure tables, giving details of the companies in whose 'relevant securities' and 'dealings' should be disclosed, can be found on the Irish Takeover Panel's website at www.irishtakeoverpanel.ie. 'Interests' in securities arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. Terms in quotation marks in this section are defined in the Irish Takeover Rules, which can also be found on the Irish Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a dealing under Rule 8, please consult the Irish Takeover Panel's website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020. No Offer or Solicitation This Announcement is for information purposes only and is not intended to, and does not, constitute or form any part of any offer or invitation, or the solicitation of an offer, to purchase or otherwise acquire, subscribe for, sell or otherwise dispose of any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Acquisition or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. The Acquisition will be made solely by means of the Scheme Document (or, if applicable, the Takeover Offer Documents), which will contain the full terms and conditions of the Acquisition, including details of how to vote in respect of the Acquisition. Any decision in respect of, or other response to, the Acquisition, should be made only on the basis of the information contained in the Scheme Document (or, if applicable, the Takeover Offer Documents). Overseas Shareholders The availability of the Acquisition to Dalata Shareholders who are not resident in and citizens of Ireland or the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are located or of which they are citizens. Persons who are not resident in Ireland or the United Kingdom should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdictions. In particular, the ability of persons who are not resident in Ireland or the United Kingdom to vote their Dalata Shares with respect to the Scheme at the Scheme Meetings, or to appoint another person as proxy to vote at the Scheme Meetings on their behalf, may be affected by the laws of the relevant jurisdictions in which they are located. Any failure to comply with the applicable restrictions may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies and persons involved in the Acquisition disclaim any responsibility or liability for the violation of such restrictions by any person. Further details in relation to Overseas Shareholders will be contained in the Scheme Document. Unless otherwise determined by Bidco or required by the Takeover Rules, and permitted by applicable law and regulation, the Acquisition will not be made available, directly or indirectly, in, into or from a Restricted Jurisdiction where to do so would violate the laws in that jurisdiction and no person may vote in favour of the Scheme by any such use, means, instrumentality or from within a Restricted Jurisdiction or any other jurisdiction if to do so would constitute a violation of the laws of that jurisdiction. Copies of this announcement and any formal documentation relating to the Acquisition are not being, and must not be, directly or indirectly, mailed or otherwise forwarded, distributed or sent in or into or from any Restricted Jurisdiction and persons receiving such documents (including custodians, nominees and trustees) must not mail or otherwise forward, distribute or send it in or into or from any Restricted Jurisdiction. Doing so may render invalid any related purported vote in respect of the Acquisition. If the Acquisition is implemented by way of a Takeover Offer (unless otherwise permitted by applicable law and regulation), the Takeover Offer may not be made directly or indirectly, in or into, or by the use of mails or any means or instrumentality (including, but not limited to, facsimile, e-mail or other electronic transmission, telex or telephone) of interstate or foreign commerce of, or of any facility of a national, state or other securities exchange of any Restricted Jurisdiction and the Takeover Offer may not be capable of acceptance by any such use, means, instrumentality or facilities. Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
ISIN: | IE00BJMZDW83, IE00BJMZDW83 |
Category Code: | MSCM |
TIDM: | DAL,DHG |
LEI Code: | 635400L2CWET7ONOBJ04 |
OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
Sequence No.: | 404286 |
EQS News ID: | 2208910 |
End of Announcement | EQS News Service |
|